Health Canada
- Status: approved
Intravitreal bevacizumab and dexamethasone implant Injection (Intravitreal bevacizumab and dexamethasone implant Injection) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Yeungnam University College of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.